... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and...

11
... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco, CA

Transcript of ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and...

Page 1: ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,

... a KAISER PERMANENTE Innovation

Applications of IndiGO to ACOs

David M Eddy MD PhDFounder and Chief Medical Officer Emeritus

ArchimedesSan Francisco, CA

Page 2: ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,

“Individualized Guidelines”IndiGO

• Quality and cost of healthcare are largely determined by guidelines

• Current guidelines are clunky • IndiGO Spans multiple conditions, risk factors,

treatments to create a single “integrated guideline”

Page 3: ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,
Page 4: ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,

Uses of IndiGO for ACOs

• Individual patient-physician decision making– Improves patient adherence– Improves outcomes– Reduces hospitalizations and costs

• Prioritize outreach programs• A personal health score• A population-level health score

Page 5: ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,

CVD Benefit

Page 6: ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,

Prioritize outreach programsA ranked list of patients

Page 7: ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,

Better prioritization increases value

• In the ARIC population• Compared to current national guidelines, treating

BP and cholesterol in order of CVD benefit– Delivered same benefit as current guidelines,

at 67% lower cost– Or delivered 43% more benefit at same cost

Page 8: ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,

Uses of IndiGO for ACOs

• Individual patient-physician decision making– During a patient visit– Direct patient access

• Prioritize outreach programs• A personal health score: “GO Score”• A population-level health GO score

Page 9: ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,

Current Benefit

Potential Benefit

Patient’s GO Score = current benefit/potential benefit = 30%

Page 10: ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,

New Benefit

Potential Benefit

Patient’s new Score = new benefit/potential benefit = 83%

Page 11: ... a KAISER PERMANENTE Innovation Applications of IndiGO to ACOs David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,

Uses of Health GO Scores

• Measure of patient’s current risk and potential benefit• Create incentives for patients and physicians• Add up individual scores to get scores for groups of patients– Physician’s panel– Health system, ACO – Geographical region– Special patient populations (e.g. elderly, diabetes)

• Measure, compare, and monitor quality • Being evaluated by NCQA